• Summary of data on the use of benzydamine hydrochloride and cetylpyridinium chloride in clinical practice

Summary of data on the use of benzydamine hydrochloride and cetylpyridinium chloride in clinical practice

SOVREMENNAYA PEDIATRIYA.2018.7(95):83-87; doi 10.15574/SP.2018.95.83

Marushko Yu. V., Asonov A. O.
Bogomolets National Medical University, Kyiv, Ukraine

The urgency of the problem of rational pharmacotherapy of inflammatory diseases of the pharynx in children is due to the widespread prevalence of this pathology. Diagnosis of acute tonsillofaringitis in children involves differentiation into probable viral and bacterial (including β-hemolytic streptococcus group A) etiology with an appropriate antimicrobial therapy algorithm. Treatment for throat pain involves the need for a non-antibacterial drug that justifies patients' expectations for rapid pain relief. The use of a fixed combination of 3 mg of benzidamine hydrochloride and 1 mg of cetylpyridinium chloride, which is part of the Septoletе Total, is effective and safe for pain relief, anti-inflammatory and antiseptic therapy of pharyngitis, mouth and gums in gingivitis and laryngitis in children and adults.

Key words: pharyngitis, children, tonsillofaringitis, benzidamine hydrochloride, cetylpyridinium chloride, Septoletе Total.

REFERENCES

1. Abaturov OIe, Kryvusha OL. (2016). Mistseva terapiia hostrykh tonzylofarynhitiv u ditei. Zdorove rebenka. 6(74): 56—62.

2. Ershova IB, Shirina TV. (2008). Problema chasto i dlitelno boleyuschih detey i metodyi optimizatsii ih lecheniya.

Zdorove rebenka. 2(11): 59—61.

3. Kosakovskiy AL, Panchenko OA, Kosakovskaya IA, Goroshko OI, Zhabinets NI, Shuh LA. (2015). O primenenii preparata Septolete so vkusom limona, yabloka, dikoy chereshni u patsientov s bolyu v gorle. Zdorove rebenka. 5: 71—74.

4. Koshyr P. (2017). Porivnialne doslidzhennia terapevtychnoi ekvivalentnosti doslidzhuvanoi i standartnoi fiksovanoi kombinatsii 3 mh benzydaminu hidrokhlorydu ta 1 mh tsetylpirydyniiu khlorydu v likuvanni boliu v horli, poviazanoho z infektsiiamy verkhnikh dykhalnykh shliakhiv. Zdorove rebenka. 12; 2: 16—21.

5. Lezhenko HO, Pashkova OIe, Hyria OM. (2014). Otsinka efektyvnosti zastosuvannia mistsevoi terapii v kompleksnomu likuvanni bakterialnoho tonzylofarynhitu u ditei. Zdorove rebenka. 32(53): 21—24.

6. Pogorelova OO, Gorelov AV, Usenko DV, Ploskireva AA. (2015). Opyit primeneniya metabolicheskogo prebiotika v lechenii ostryih respiratornyih zabolevaniy u detey. Voprosyi prakticheskoy pediatrii. 10; 4: 61—65.

7. Romantsov MG. (2008). Ratsionalnaya farmakoterapiya chasto boleyuschih detey. Sankt-Peterburg: 76.

8. Shahtel BP, Paddzharino DA. (2012). Randomizirovannaya dvoynaya slepaya platsebo-kontroliruemaya model, demonstriruyuschaya mestnyiy effekt benzidamina u detey s tonzillofaringitom. Zdorove rebenka. 8(43): 73—76.

9. Cingi C, Songu M, Ural A, Erdogmus N, Yildirim M, Cakli H, Bal C. (2011, Jun). Effect of chlorhexidine gluconate and benzydamine-hydrochloride mouth spray on clinical signs and quality of life of patients with streptococcal tonsillopharyngitis: multicentre, prospective, randomised, double-blinded, placebo-controlled study. J Laryngol Otol. 125(6): 620—5. https://doi.org/10.1017/S0022215111000065; PMid:21310101

10. Gulliford M, Latinovic R, Charlton J, Little P, van Staa T, Ashworth M. (2009). Selective decrease in consultations and antibiotic prescribing for acute respiratory tract infections in UK primary care up to 2006. J Public Health (Oxf). 31(4): 512—520. https://doi.org/10.1093/pubmed/fdp081; PMid:19734168 PMCid:PMC2781723

11. Lasseter GM, McNulty CA, Richard Hobbs FD. (2009). In vitro evaluation of five rapid antigen detection tests for group A beta-haemolytic streptococcal sore throat infections. Fam Pract. 26(6): 437—444. https://doi.org/10.1093/fampra/cmp054; PMid:19748913

12. Mclsaac WJ, Goel V, To T, Low DE. (2000). The validity of sore throat score in family practice. CMAJ. 163(7): 811—15.

13. Pina-Vaz C et al. (2000). Antifungal Activity of local anaesthetic against Candida Species. Infectious Diseaes in obstetrics and gynecology. 8: 124—37.

14. Prats G. (2001). Study of Benzydamine in-vitro Activity against different bacterial strains of clinical interest. Servicio de Microbiologia. Barcelona, Spain.

15. Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, Martin JM, Van Beneden C. (2012). Infectious Diseases Society of America. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis. 55(10): 86—102. https://doi.org/10.1093/cid/cis629; https://doi.org/10.1093/cid/cis847; PMid:23091044

16. Simard-Savoie S, Forest D. (1978). Topical anaesthetic activity of benzydamine Curr Ther Res. 23: 734—45.

17. Sironi M et al. (1997). Benzydamine inhibits the release of tumor necrosis factor-α and monocyte chemotactic protein-1 by Candida albicansstimulated human peripheral blood cells. Int J Clin Lab Res. 27(2): 118–22. https://doi.org/10.1007/BF02912445; PMid:9266282

18. Williams BG, Gouws E, Boschi-Pinto C, Bryce C, Dye C. (2002). Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet. Infect. Dis. 2: 25—32. https://doi.org/10.1016/S1473-3099(01)00170-0

19. Worrall GJ. (2007). Acute sore throat. Can Fam Physician. 53(11): 1961—1962. PMid:18000276 PMCid:PMC2231494

Article received: May 21, 2018. Accepted for publication: Nov 10, 2018.